Vitreomacular adhesion (VMA) is a significant eye condition that can affect vision and overall ocular health. Understanding this condition is essential for early detection and management, which can prevent more severe complications. In this comprehensive guide, we will delve into the causes, symptoms, diagnosis, and treatment options for VMA.

Vitreomacular adhesion occurs when the vitreous, a gel-like substance that fills the eye, abnormally adheres to the macula, the central part of the retina responsible for sharp, detailed vision. Normally, the vitreous separates from the retina as we age, but in some cases, it remains attached, causing traction and potential vision problems.

The vitreous humor is crucial in maintaining the eye’s shape and providing a pathway for light to reach the retina. It is composed mainly of water (about 99%) and a network of collagen fibers and hyaluronic acid. As we age, the vitreous begins to liquefy and contract, a process known as vitreous syneresis. In a healthy aging process, the vitreous detaches completely from the retina, a process termed posterior vitreous detachment (PVD). However, in some individuals, the detachment is incomplete, and the vitreous remains partially attached to the macula, leading to vitreomacular adhesion.

Mechanism of Adhesion: The adhesion occurs due to the persistent attachment of the vitreous cortex to the macular surface. This attachment can exert tractional forces on the macula, potentially leading to structural changes and visual disturbances.

Classification: VMA can be classified based on its extent and the presence of additional retinal pathology:

• Focal VMA: Involves a small area of adhesion (≤1500 microns in diameter).
• Broad VMA: Involves a larger area of adhesion (>1500 microns in diameter).
• Isolated VMA: Occurs without associated retinal pathology.
• VMA with concurrent macular disease: Can occur alongside conditions like age-related macular degeneration (AMD) or diabetic retinopathy.

The primary cause of VMA is age-related changes in the eye. As we age, the vitreous undergoes a process called syneresis, where it liquefies and shrinks. Ideally, this leads to a complete detachment from the retina. However, if the vitreous only partially detaches and remains adherent to the macula, it results in VMA. Other contributing factors include:

• Diabetic Retinopathy: Patients with diabetes may experience abnormal blood vessel growth and changes in the vitreous, increasing the risk of VMA. Diabetic retinopathy causes the retinal blood vessels to leak or grow abnormally, which can lead to changes in the vitreous structure and its attachment to the retina.
• Trauma: Eye injuries can disrupt the normal separation of the vitreous from the retina. Blunt or penetrating trauma can cause immediate or delayed vitreomacular adhesion.
• Inflammatory Conditions: Diseases causing inflammation in the eye, such as uveitis, can alter the vitreous and retina relationship, leading to VMA. Chronic inflammation can cause the vitreous to adhere more firmly to the retina.
• Surgical Interventions: Previous eye surgeries, particularly those involving the retina or vitreous, can increase the risk of VMA by causing scar tissue formation or altering the normal vitreoretinal interface.
• Myopia (Nearsightedness): High myopia can lead to changes in the vitreous structure, increasing the risk of VMA.
• Pathophysiology: In VMA, the vitreous remains attached to the macula due to persistent adhesion points. This incomplete detachment can exert tangential and anterior-posterior traction on the macula, potentially leading to macular holes, cystoid macular edema, or other macular disorders.

VMA can be asymptomatic in its early stages, but as the condition progresses, it can cause noticeable visual disturbances, such as:

• Blurred Vision: The traction on the macula can distort central vision, making it blurry or out of focus. This blurriness can affect daily activities such as reading, driving, or recognizing faces.
• Distorted Vision: Straight lines may appear wavy or bent, a condition known as metamorphopsia. This distortion occurs because the macula, responsible for central vision, is being pulled and distorted by the adhered vitreous.
• Decreased Visual Acuity: Difficulty in seeing fine details or reading small print. This can lead to challenges in performing tasks that require sharp vision.
• Floaters: Small, shadowy shapes that move across the field of vision due to changes in the vitreous. While floaters are common in PVD, their sudden increase can indicate a more serious condition like VMA.

Additional symptoms may include:

• Central Scotomas: Dark or blind spots in the central vision. These scotomas can interfere with activities requiring precise vision, such as reading or recognizing faces.
• Color Vision Changes: Difficulty distinguishing between colors or noticing that colors appear washed out. This can affect the perception of contrast and color saturation.
• Progression: If left untreated, VMA can progress to more severe conditions such as vitreomacular traction syndrome (VMT), where the tractional forces are strong enough to cause macular edema, macular holes, or retinal detachment.

Diagnosis of VMA involves a thorough eye examination by an ophthalmologist, including:

• Optical Coherence Tomography (OCT): This non-invasive imaging test provides detailed cross-sectional images of the retina and vitreous, allowing for the identification of adhesions and their effect on the macula. OCT can precisely measure the thickness of the retina and the extent of the adhesion. It is the gold standard for diagnosing VMA and monitoring its progression.
• Fundus Examination: Using special lenses and lights to examine the retina and vitreous. This examination helps identify any changes in the retina’s appearance due to VMA. Indirect ophthalmoscopy or slit-lamp biomicroscopy may be used for a detailed view of the vitreoretinal interface.
• Visual Acuity Test: Measuring the sharpness of vision to assess the impact of VMA on sight. This test helps determine how much the VMA is affecting central vision.
• Fluorescein Angiography: A dye is injected into the bloodstream, and pictures are taken to see if there is any leakage from the retinal blood vessels, which can be associated with VMA complications. This test helps identify areas of macular edema or neovascularization.
• Amsler Grid Test: Patients look at a grid of horizontal and vertical lines to check for distortions, which can help identify central vision issues related to VMA. Any distortion or missing lines on the grid can indicate macular involvement.

Treatment for VMA depends on the severity of symptoms and the impact on vision. Options include:

• Observation: For mild cases with minimal symptoms, regular monitoring may be sufficient. An ophthalmologist will schedule periodic exams to check for progression. Observation is often recommended when the adhesion does not significantly impact vision and there is no sign of macular damage.
• Pharmacologic Treatment:
  • Ocriplasmin (Jetrea): This medication is injected into the eye and works by dissolving the proteins causing the adhesion, facilitating the separation of the vitreous from the macula. Ocriplasmin is a proteolytic enzyme that specifically targets the fibronectin and laminin proteins in the vitreoretinal interface. It is typically considered when there is a high likelihood of adhesion release without the need for surgery. The injection is performed in a clinical setting, and patients are monitored for possible side effects such as visual disturbances or retinal tears.
• Surgical Treatment
  • Vitrectomy: In more severe cases or when vision is significantly affected, vitrectomy surgery is considered. This procedure involves removing the vitreous gel and relieving the traction on the macula. It is typically successful in restoring vision but carries risks such as infection, retinal detachment, or cataract formation. During vitrectomy, the surgeon may also perform additional procedures, such as peeling the internal limiting membrane (ILM) to reduce the risk of recurrence. Advances in surgical techniques, including small-gauge vitrectomy and improved instrumentation, have made this procedure safer and more effective.
• Laser Therapy: Though less common, laser treatment can sometimes be used to address complications arising from VMA, such as macular holes. Laser therapy aims to create small burns around the macular hole to promote sealing and closure. This approach is usually considered when other treatments are not suitable or have failed.
• Emerging Treatments: Research is ongoing to develop new pharmacologic agents and minimally invasive techniques to treat VMA. These include enzyme-based treatments that target different components of the vitreoretinal interface and novel drug delivery systems.

While age-related VMA cannot be entirely prevented, maintaining overall eye health can reduce the risk of complications. Regular eye exams, managing systemic conditions like diabetes, and protecting the eyes from injury are essential preventive measures.

Additional preventive tips include:

• Healthy Diet: Consuming a diet rich in antioxidants, vitamins, and minerals can support eye health. Foods like leafy greens, fish, nuts, and fruits are beneficial. Nutrients such as lutein, zeaxanthin, omega-3 fatty acids, and vitamins A, C, and E are particularly important for retinal health.
• Exercise: Regular physical activity improves blood circulation, which is essential for eye health. Exercise helps maintain overall cardiovascular health, which in turn supports healthy blood flow to the eyes.
• Avoid Smoking: Smoking is a risk factor for many eye diseases, including those that can lead to VMA. Quitting smoking can significantly reduce the risk of developing eye conditions.
• Control Blood Sugar Levels: For individuals with diabetes, maintaining tight control of blood sugar levels can prevent diabetic retinopathy, which is a risk factor for VMA.
• Protective Eyewear: Using protective eyewear during activities that pose a risk of eye injury can help prevent trauma-induced VMA.
• Regular Eye Examinations: Regular visits to an eye care professional are crucial for early detection and management of any changes in the vitreoretinal interface. Comprehensive eye exams should include dilated fundus examinations and OCT imaging, especially for individuals at higher risk of VMA.

Vitreomacular adhesion is a condition that warrants attention due to its potential to affect vision significantly. Early detection and appropriate management are crucial in preserving sight and preventing further complications. If you experience any symptoms associated with VMA, seek advice from an eye care professional promptly. With advancements in diagnostic techniques and treatment options, managing VMA effectively is more achievable than ever.

By staying informed and proactive about eye health, you can ensure the best possible outcomes for your vision and overall well-being. Regular check-ups, healthy lifestyle choices, and prompt medical attention for any visual disturbances are key to maintaining optimal eye health.

World Eye Care Foundation’s eyecare.live brings you the latest information from various industry sources and experts in eye health and vision care. Please consult with your eye care provider for more general information and specific eye conditions. We do not provide any medical advice, suggestions or recommendations in any health conditions.